|
1.
|
Chen BJ: Triptolide, a novel
immunosuppressive and anti-inflammatory agent purified from a
Chinese herb Tripterygium wilfordii Hook F. Leuk Lymphoma.
42:253–265. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Qiu D and Kao PN: Immunosuppressive and
anti-inflammatory mechanisms of triptolide, the principal active
diterpenoid from the Chinese medicinal herb Tripterygium
wilfordii Hook. f. Drugs R D. 4:1–18. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Shamon LA, Pezzuto JM, Graves JM, et al:
Evaluation of the mutagenic, cytotoxic and antitumor potential of
triptolide, a highly oxygenated diterpene isolated from
Tripterygium wilfordii. Cancer Lett. 112:113–117. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Tengchaisri T, Chawengkirttikul R,
Rachaphaew N, Reutrakul V, Sangsuwan R and Sirisinha S: Antitumor
activity of triptolide against cholangiocarcinoma growth in vitro
and in hamsters. Cancer Lett. 133:169–175. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Lee KY, Chang W, Qiu D, Kao PN and Rosen
GD: PG490 (triptolide) cooperates with tumor necrosis factor-α to
induce apoptosis in tumor cells. J Biol Chem. 274:13451–13455.
1999.PubMed/NCBI
|
|
6.
|
Chan EW, Cheng SC, Sin FW and Xie Y:
Triptolide induced cytotoxic effects on human promyelocytic
leukemia, T cell lymphoma and human hepatocellular carcinoma cell
lines. Toxicol Lett. 122:81–87. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Tsuruo T, Naito M, Tomida A, et al:
Molecular targeting therapy of cancer: drug resistance, apoptosis
and survival signal. Cancer Sci. 94:15–21. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Debatin KM: Apoptosis pathways in cancer
and cancer therapy. Cancer Immunol Immunother. 53:153–159. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Levine B, Sinha S and Kroemer G: Bcl-2
family members: dual regulators of apoptosis and autophagy.
Autophagy. 4:600–606. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Yang Y, Liu Z, Tolosa E, Yang J and Li L:
Triptolide induces apoptotic death of T lymphocyte.
Immunopharmacology. 40:139–149. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Aggarwal BB: Nuclear factor-κB: the enemy
within. Cancer Cell. 6:203–208. 2004.
|
|
12.
|
Karin M: Nuclear factor-κB in cancer
development and progression. Nature. 441:431–436. 2006.
|
|
13.
|
Keyse SM: Protein phosphatases and the
regulation of mitogen-activated protein kinase signaling. Curr Opin
Cell Biol. 12:186–192. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Liu Q: Triptolide and its expanding
multiple pharmacological functions. Int Immunopharmacol.
11:377–383. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Zhu W, Hu H, Qiu P and Yan G: Triptolide
induces apoptosis in human anaplastic thyroid carcinoma cells by a
p53-independent but NF-κB-related mechanism. Oncol Rep.
22:1397–1401. 2009.PubMed/NCBI
|
|
16.
|
Kim MJ, Lee TH, Kim SH, Choi YJ, Heo J and
Kim YH: Triptolide inactivates Akt and induces caspase-dependent
death in cervical cancer cells via the mitochondrial pathway. Int J
Oncol. 37:1177–1185. 2010.PubMed/NCBI
|
|
17.
|
Pigneux A, Mahon FX, Uhalde M, et al:
Triptolide cooperates with chemotherapy to induce apoptosis in
acute myeloid leukemia cells. Exp Hematol. 36:1648–1659. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Yinjun L, Jie J and Yungui W: Triptolide
inhibits transcription factor NF-kappaB and induces apoptosis of
multiple myeloma cells. Leuk Res. 29:99–105. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Carter BZ, Mak DH, Schober WD, et al:
Triptolide induces caspase-dependent cell death mediated via the
mitochondrial pathway in leukemic cells. Blood. 108:630–637. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Kim R, Emi M and Tanabe K:
Caspase-dependent and -independent cell death pathways after DNA
damage (Review). Oncol Rep. 14:595–599. 2005.PubMed/NCBI
|
|
21.
|
Denault JB and Salvesen GS: Caspases: keys
in the ignition of cell death. Chem Rev. 102:4489–4500. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Tao Y, Zhang ML, Ma PC, et al: Triptolide
inhibits proliferation and induces apoptosis of human melanoma A375
cells. Asian Pac J Cancer Prev. 13:1611–1615. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Chao DT and Korsmeyer SJ: BCL-2 family:
regulators of cell death. Annu Rev Immunol. 16:395–419. 1998.
View Article : Google Scholar
|
|
24.
|
Li J, Zhu W, Leng T, et al:
Triptolide-induced cell cycle arrest and apoptosis in human renal
cell carcinoma cells. Oncol Rep. 25:979–987. 2011.PubMed/NCBI
|
|
25.
|
Zhou GX, Ding XL, Huang JF, et al:
Apoptosis of human pancreatic cancer cells induced by Triptolide.
World J Gastroenterol. 14:1504–1509. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Lee KY, Park JS, Jee YK and Rosen GD:
Triptolide sensitizes lung cancer cells to TNF-related
apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition
of NF-κB activation. Exp Mol Med. 34:462–468. 2002.PubMed/NCBI
|
|
27.
|
Frese S, Pirnia F, Miescher D, et al:
PG490-mediated sensitization of lung cancer cells to
Apo2L/TRAIL-induced apoptosis requires activation of ERK2.
Oncogene. 22:5427–5435. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Rubinfeld H and Seger R: The ERK cascade:
a prototype of MAPK signaling. Mol Biotechnol. 31:151–174. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Fan M and Chambers TC: Role of
mitogen-activated protein kinases in the response of tumor cells to
chemotherapy. Drug Resist Updat. 4:253–267. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Davis RJ: The mitogen-activated protein
kinase signal transduction pathway. J Biol Chem. 268:14553–14556.
1993.PubMed/NCBI
|
|
31.
|
Lee SJ, Park K, Ha SD, Kim WJ and Moon SK:
Gleditsia sinensis thorn extract inhibits human colon cancer cells:
the role of ERK1/2, G2/M-phase cell cycle arrest and p53
expression. Phytother Res. 24:1870–1876. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Yin Y, Guan Y, Duan J, et al:
Cardioprotective effect of Danshensu against myocardial
ischemia/reperfusion injury and inhibits apoptosis of H9c2
cardiomyocytes via Akt and ERK1/2 phosphorylation. Eur J Pharmacol.
699:219–226. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Stanciu M, Wang Y, Kentor R, et al:
Persistent activation of ERK contributes to glutamate-induced
oxidative toxicity in a neuronal cell line and primary cortical
neuron cultures. J Biol Chem. 275:12200–12206. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Wang X, Martindale JL and Holbrook NJ:
Requirement for ERK activation in cisplatin-induced apoptosis. J
Biol Chem. 275:39435–39443. 2000. View Article : Google Scholar
|
